OOIR: Observatory of International Research

Papers

(The H4-Index of Oncology Letters is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Resectability in bronchogenic carcinoma: A single‑center experience	70
A novel quantitative model based on gross tumor volume corresponding to anatomical distribution measured with multidetector computed tomography to determine the resectability of non‑distant metastatic	46
The impact of primary region resection on the therapeutic outcome of combination regimens for metastatic renal cell carcinoma	40
A novel fluorescent dye selectively images and kills cancer stem cells by targeting mitochondria: Evidence from a cell line‑based zebrafish xenograft model	40
Cadherin‑16 inhibits thyroid carcinoma cell proliferation and invasion	38
Clinical feasibility of modified procarbazine and lomustine chemotherapy without vincristine as a salvage treatment for recurrent adult glioma	33
Long non‑coding RNA MIR17HG sponges microRNA‑21 to upregulate PTEN and regulate homoharringtonine‑based chemoresistance of acute myeloid leukemia cells	32
P4HA2 promotes cell proliferation and migration in glioblastoma	32
Response of human cancer cells to simultaneous treatment with sorafenib and radiofrequency current	31
Prognostic value of circWWC3 as a novel survival‑related biomarker for clear cell renal cell carcinoma	29
Cetuximab or nimotuzumab in combination with chemotherapy for treating recurrent/metastatic nasopharyngeal carcinoma: A meta‑analysis and systemic review	29
Synchronous primary colorectal mucinous adenocarcinoma and pancreatic ductal adenocarcinoma: A case report	28
Novel predictive nomograms based on aspartate aminotransferase‑to‑platelet ratio index for hepatocellular carcinoma with post‑operative adjuvant transarterial chemoembolization	28
Effect of IFN‑γ encapsulated liposomes on major signal transduction pathways in the lymphocytes of patients with lung cancer	28
Mucosa‑associated lymphoid tissue in the central nervous system presenting as meningioma: A case report	27
Efficacy and outcome analysis: Combination of Endostar and chemotherapy as a neoadjuvant treatment of stage IIIA/IIIB squamous cell lung cancer	27
Pretreatment high cholesterol and low neutrophils predict complete pathological response after neoadjuvant short‑course radiotherapy followed by chemotherapy and immunotherapy in locally advanced rect	27
IDH2: A novel biomarker for environmental exposure in blood circulatory system disorders (Review)	26
[Corrigendum] Dihydroartemisinin suppresses proliferation, migration, the Wnt/β‑catenin pathway and EMT via TNKS in gastric cancer	26
Synchronous ipsilateral papillary renal cell carcinoma and urothelial carcinoma: A case report	26
Multiple synchronous primary malignant neoplasms: A case report and literature review	25
Androgen receptor axis‑targeted agents are not superior to conventional hormonal therapy for treatment of metastatic prostate cancer	25
Analysis of the expression, function and signaling of glycogen phosphorylase isoforms in hepatocellular carcinoma	25
Role of NELF‑B in supporting epithelial‑mesenchymal transition and cell proliferation during hepatocellular carcinoma progression	25
Excision repair cross‑complementing group 2 upregulation is a potential predictive biomarker for oral squamous cell carcinoma recurrence	24

Heat shock protein 20 suppresses breast carcinogenesis by inhibiting the MAPK and AKT signaling pathways	24
Cancer marker TNFRSF1A: From single‑cell heterogeneity of renal cell carcinoma to functional validation	24
Pan‑cancer analysis on the role of KMT2C expression in tumor progression and immunotherapy	24
A pilot study on the detection of microsatellite instability using long mononucleotide repeats in solid tumors	24